Processing Speed Differences between Attention-Deficit Hyperactivity Disorder Groups with and without Co-Morbid Anxiety Diagnoses

被引：0
|
作者：
Frick, Lauren A.
Van Winkle, Baylee
Balloun, Bailey A.
Bailey-Bila, Maggie C.
Fawcett, Madelyn K.
Kern, Jennie R.
Wenzel, Benjamin G.
Pyykkonen, Benjamin A.
机构：
来源：
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY | 2022年 / 37卷 / 06期
关键词：
D O I：
10.1093/arclin/acac060.164
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
A - 164
引用
收藏
页码：1319 / 1319
页数：1
相关论文
共 50 条
  • [1] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Dell'Agnello, Grazia
    Zuddas, Alessandro
    Masi, Gabriele
    Curatolo, Paolo
    Besana, Dante
    Rossi, Andrea
    [J]. CNS DRUGS, 2009, 23 (09) : 739 - 753
  • [2] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Grazia Dell’Agnello
    Alessandro Zuddas
    Gabriele Masi
    Paolo Curatolo
    Dante Besana
    Andrea Rossi
    [J]. CNS Drugs, 2009, 23 : 739 - 753
  • [3] Gender Differences in Processing Speed in Children with Attention-deficit/Hyperactivity Disorder
    Trammell, B.
    Mazur-Mosiewicz, A.
    Dean, R.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (06) : 486 - 486
  • [4] Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates
    Einarsson, Emil
    Sigurdsson, Jon Fridrik
    Gudjonsson, Gisli H.
    Newton, Anna Kristin
    Bragason, Olafur Orn
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2009, 63 (05) : 361 - 367
  • [5] Prevalence of attention-deficit/hyperactivity disorder and co-morbid disorders among students of Cumhuriyet University
    Kavakci, Onder
    Kugu, Nesim
    Semiz, Murat
    Meydan, Feride
    Karsikaya, Sureyya
    Dogan, Orhan
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2012, 26 (02): : 107 - 117
  • [6] Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction
    Perez de los Cobos, Jose
    Sinol, Nuria
    Perez, Victor
    Trujols, Joan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (02) : 337 - 356
  • [7] Treatment Response in Depressed Adolescents With and Without Co-Morbid Attention-Deficit/Hyperactivity Disorder in the Treatment for Adolescents with Depression Study
    Kratochvil, Christopher J.
    May, Diane E.
    Silva, Susan G.
    Madaan, Vishal
    Puumala, Susan E.
    Curry, John F.
    Walkup, John
    Kepley, Hayden
    Vitiello, Benedetto
    March, John S.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 519 - 527
  • [8] Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): A neurobiologic ally and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)
    Diamond, A
    [J]. DEVELOPMENT AND PSYCHOPATHOLOGY, 2005, 17 (03) : 807 - 825
  • [9] Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
    Cunill, R.
    Castells, X.
    Tobias, A.
    Capella, D.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (01) : 15 - 23
  • [10] The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder
    Guenther, Thomas
    Herpertz-Dahlmann, Beate
    Jolles, Jellemer
    Konrad, Kerstin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 725 - 735
12345